Together, these data indicate that Msh2 is a critical modifier that acts within MSNs to accelerate CAG repeat length-dependent mutant huntingtin phenotypes that are reflective of an ongoing HD-relevant pathogenic process. This evidence concerns the gene MSH2 and Huntington disease.